Cancer Head and Neck Cancer Therapy Area Pipeline Report

Monday, February 15, 2010 Cancer News J E 4
Cancer Head and Neck Cancer Therapy Area Pipeline Report This report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. ( ) Scope of the report: Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines by company and by stage for each specific therapy area. The latest news by company also ensures that each report is fresh and up-to-date. In addition to new developments and disease specific pipeline projects each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Full pipeline details by stage are provided and include detailed product descriptions information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products. Key benefits • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas. • Keep track of your competitors and partners by better understanding their product pipeline. • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas. • Maintain a critical competitive advantage. To know more and to buy a copy of your report feel free to visit : Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Blog: Follow us on twitter:


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Sinovac Completes Acquisition Aimed at Expanding P...
Cell Science Systems - The ALCAT Laboratory - Beco...